National Healthcare Properties (NASDAQ:NHP) Raised to Buy at Wall Street Zen

National Healthcare Properties (NASDAQ:NHP) was upgraded by Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued to investors on Saturday, Wall Street Zen reports.

NHP has been the topic of several other research reports. Citizens Jmp boosted their target price on shares of National Healthcare Properties from $18.00 to $21.00 and gave the stock a “market outperform” rating in a report on Monday, August 10th. Citigroup restated an “outperform” rating on shares of National Healthcare Properties in a research report on Monday, August 10th. Wells Fargo & Company raised their target price on shares of National Healthcare Properties from $17.00 to $19.00 and gave the company an “overweight” rating in a research note on Tuesday, September 1st. Weiss Ratings initiated coverage on shares of National Healthcare Properties in a research note on Monday, July 20th. They set a “sell (d)” rating for the company. Finally, Huntington initiated coverage on shares of National Healthcare Properties in a report on Friday, July 17th. They issued an “outperform” rating and a $18.00 price target on the stock. Six investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $18.22.

National Healthcare Properties Stock Performance

NASDAQ NHP opened at $15.55 on Friday. The business has a 50 day simple moving average of $16.19. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.45. National Healthcare Properties has a 12 month low of $11.25 and a 12 month high of $17.46. The stock has a market cap of $1.13 billion and a PE ratio of -119.62.

National Healthcare Properties (NASDAQ:NHP) last posted its quarterly earnings results on Wednesday, August 5th. The company reported ($0.13) earnings per share for the quarter. National Healthcare Properties had a negative return on equity of 6.22% and a negative net margin of 13.04%. The business had revenue of $87.53 million during the quarter. During the same period last year, the firm earned ($0.85) EPS. On average, analysts forecast that National Healthcare Properties will post 0.70 EPS for the current fiscal year.

Hedge Funds Weigh In On National Healthcare Properties

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Alyeska Investment Group L.P. bought a new stake in National Healthcare Properties in the 2nd quarter worth approximately $37,278,000. State Street Corp purchased a new stake in shares of National Healthcare Properties during the 2nd quarter worth approximately $8,975,000. Irenic Capital Management LP bought a new position in shares of National Healthcare Properties during the 2nd quarter valued at approximately $8,052,000. Citadel Advisors LLC bought a new position in shares of National Healthcare Properties during the 2nd quarter valued at approximately $7,325,000. Finally, Squarepoint Ops LLC bought a new position in shares of National Healthcare Properties during the 2nd quarter valued at approximately $5,233,000.

National Healthcare Properties Company Profile

National Healthcare Properties, Inc was a U.S.-based real estate investment trust focused on healthcare-related properties. The company’s portfolio consisted primarily of income-producing healthcare facilities, including skilled nursing centers, assisted-living communities, and other properties used by healthcare providers.

Its business model was based on acquiring healthcare real estate and leasing those properties to operators under long-term agreements. Through this approach, National Healthcare Properties sought to generate rental income from facilities serving aging and medically dependent populations.

National Healthcare Properties was historically associated with the U.S.